Benede Ubieto, RaquelEstévez Vázquez, OlgaMartínez Naves, EduardoRegueiro González-Barros, José RamónCubero Palero, Francisco JavierNevzorova, Yulia2024-01-092024-01-092021-03-03Benedé-Ubieto, R., Estévez-Vázquez, O., Flores-Perojo, V., Macías-Rodríguez, R.U., Ruiz-Margáin, A., Martínez-Naves, E., Regueiro, J.R., Ávila, M.A., Trautwein, C., Bañares, R., Bosch, J., Cubero, F.J., Nevzorova, Y.A., 2021. Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain. Journal of Clinical Medicine 10, 1039.. https://doi.org/10.3390/jcm100510392077-038310.3390/jcm10051039https://hdl.handle.net/20.500.14352/91977The outbreak of the novel coronavirus SARS-CoV-2 epidemic has rapidly spread and still poses a serious threat to healthcare systems worldwide. In the present study, electronic medical records containing clinical indicators related to liver injury in 799 COVID-19-confirmed patients admitted to a hospital in Madrid (Spain) were extracted and analyzed. Correlation between liver injury and disease outcome was also evaluated. Serum levels of Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Gamma-glutamyltransferase (GGT), Alkaline phosphatase (ALP), Lactate dehydrogenase (LDH) and AST/ALT ratio were elevated above the Upper Limit of Normal (ULN) in 25.73%, 49.17%, 34.62%, 24.21%, 55.84% and 75% of patients, respectively. Interestingly, significant positive correlation between LDH levels and the AST/ALT ratio with disease outcome was found. Our data showed that SARS-CoV-2 virus infection leads to mild, but significant changes in serum markers of liver injury. The upregulated LDH levels as well as AST/ALT ratios upon admission may be used as additional diagnostic characteristic for COVID-19 patients.engAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/journal articlehttps://www.mdpi.com/2077-0383/10/5/1039open access612.017SARS-CoV-2Liver injuryPandemicAST/ALT ratioFerritinCiencias Biomédicas2412 Inmunología